Delivery Order SPE2DB22D2007-SPE2DB25FJ4VH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $35,435.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 9, 2025, for Zepbound 7.5 mg/0.5 mL pens. The contract, which carries an ultimate completion date of September 10, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $80,070.90 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by September 3, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on September 2, 2025, for Zepbound 5 mg/0.5 mL pen injections. This firm fixed price delivery order, valued at $5,405.58, was awarded without set-aside provisions and is scheduled for completion by September 3, 2025. The order will be fulfilled at the contractor's Conshohocken location and represents a small-value...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,202.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,812.90 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, with completion scheduled for August 18, 2025. The contract covers the supply of Zepbound 5 mg/0.5 mL pen injections and represents a non-competitive, competitively awarded delivery order under the company's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pens valued at $17,343.17 with a firm fixed price contract type. This order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $13,493.92 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. The contract is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside basis through competitive procurement, reflecting AmerisourceBergen's established capability to fulfill federal...
- The Defense Logistics Agency awarded a $9,018.43 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The contract, which is not set-aside and operates under firm fixed pricing, is scheduled for completion by September 2, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4VHDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,040.82 by the Defense Logistics Agency (DLA) for Zepbound 5 mg/0.5 ml pens. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitive award issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The delivery order falls within AmerisourceBergen's extensive federal procurement portfolio supporting the Defense Health Agency and other government healthcare systems. AmerisourceBergen maintains a significant presence as a critical vendor in the federal medical supply chain, regularly fulfilling orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The performance location for this order is the company's corporate office in Conshohocken, Pennsylvania. This award exemplifies the company's ongoing role as a primary supplier of pharmaceutical products to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 9/10/25 |